Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05732038 · ClinicalTrials.gov registry record · NA
STRIDE: Stress Reduction in Dementia Caregivers
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 93
- Enrollment target
NCT05732038: Completed NA study, sponsored by Massachusetts General Hospital.
NCT05732038 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 93 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05732038, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
Study Summary
The investigators aim to conduct a feasibility, proof of concept randomized controlled trial (RCT) of a smartphone app intervention (Healthy Minds Program; HMP) versus Wellness app (WA) among heterogeneous stressed caregivers of individuals with Alzheimer's disease and related dementias (ADRD). The investigators will test its feasibility (primary outcomes) and its preliminary effect in improvement in caregiver stress, emotional distress (depression and anxiety), and mindfulness. Participants will be randomized to one of the two conditions described above
Interventions
- BEHAVIORAL Healthy Minds Program (HMP)
- BEHAVIORAL Wellness App (WA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2023-02-20 |
| Est. Completion | 2024-06-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05732038
The ClinicalTrials.gov registry entry for NCT05732038 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Healthy Minds Program (HMP) is the first listed.
NCT05732038 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05732038 about?
NCT05732038 is a clinical study titled "STRIDE: Stress Reduction in Dementia Caregivers". The investigators aim to conduct a feasibility, proof of concept randomized controlled trial (RCT) of a smartphone app intervention (Healthy Minds Program; HMP) versus Wellness app (WA) among heterogeneous stressed caregivers of individuals with Alzheimer's disease and related dementias (ADRD). The ...
What is the current status of trial NCT05732038?
This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2023-02-20. Estimated completion is 2024-06-03.
What interventions are being tested in trial NCT05732038?
The interventions under investigation include: Healthy Minds Program (HMP) (BEHAVIORAL), Wellness App (WA) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05732038?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.